This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,964.09 firm fixed-price delivery order is for the procurement of M-M-R II vaccine vials, with a completion date of November 19, 2024.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is likely a delivery order issued against that larger IDC mechanism, enabling efficient government procurement of essential vaccines and other critical medical commodities to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract award did not have a set-aside designation, indicating open competition.
Generated 2/17/25, 9:44 PM